Driven by innovation and patient-centricity, our design and development expertise, drug device final assembly, pack and test, and advanced drug delivery packaging capabilities offer flexible solutions for a diverse portfolio of conventional and specialty injectable drug products.
Our scalable technologies deliver an output range from 3 units per minute to 300 units per minute. This unique offering enables us to manage dynamic client volumes of biopharmaceutical therapies and ultra orphan, niche personalized medicines to large-volume treatments and from clinical development through to commercial launch.
Tailored to your unique requirements, we offer a complete range of capabilities, services and expertise.
Drug device product final assembly, pack and test including:
Prefilled syringe assembly, pack and test
Pen, autoinjector, and on body injector final assembly, pack and test
Safety syringe assembly, pack and test and precision labeling
Injectable packaging for all dosage types
Expert design process focused on human-factors engineering and technical functionality
Optimizing designs for manufacturability, scalability and automation
End-to-end drug-device combination packaging
Integrated top-load cartoning
In-process testing and final release
Serialization
Cold Chain storage
Clinical Through Commercial Launch
With true customer focus and flexibility at the core of our pharmaceutical packaging service offering, we are able to adapt to the unique requirements of each global market from concept to commercialization.
PCI is an integrated partner, providing scalable packaging services to support a full range of biopharmaceuticals from ultra-orphan drugs through to large-scale therapies with tailored injectable packaging solutions.
Drug-device combination product assembly, pack and test
We take pride in celebrating the accomplishments and accolades that distinguish PCI Pharma Services, our employees, and our services. These achievements are a testament to our commitment to excellence, innovation, and the unwavering dedication of our teams
